pmed.1003534.g002.tif (571.42 kB)
Estimated cervical cancer cases averted.
figure
posted on 2021-03-11, 18:29 authored by Jane J. Kim, Kate T. Simms, James Killen, Megan A. Smith, Emily A. Burger, Stephen Sy, Catherine Regan, Karen CanfellCompared to status quo human papillomavirus (HPV) vaccination, cervical cancer cases averted were projected to continually increase as vaccination extended to women and men ages 30 years (blue), 35 years (orange), 40 years (grey), and 45 years (yellow). Results were calculated based on model projections over the lifetime of 10-year-old girls born in 1969–2009.
